Effects of Continuous Positive Airway Pressure Versus Supplemental Oxygen on 24-hour Ambulatory Blood Pressure.
From: Department of Medicine, School of Medicine, University of California, San Diego, CA, USA. d1norman@ucsd.edu
Hypertension
- Publish Date: May 2006
- ISSN: 1524-4563
- Volume: 47
- Issue: 5
- Pages: 840-5
- Medium: Internet
- Language: English
- Citation (JAMA): Norman Daniel, Loredo José S, Nelesen Richard A, et al. Effects of Continuous Positive Airway Pressure Versus Supplemental Oxygen on 24-hour Ambulatory Blood Pressure.. Hypertension May 2006;47:840-5
Abstract
Obstructive sleep apnea (OSA) is associated with recurrent episodes of nocturnal hypoxia and increased risk for development of systemic hypertension. Prior studies have been limited, however, in their ability to show reduction in blood pressure after continuous positive airway pressure (CPAP) therapy, and the effect of supplemental oxygen alone on blood pressure in OSA has not been evaluated. We performed a randomized, double-blind, placebo-controlled study comparing the effects of 2 weeks of CPAP versus sham-CPAP versus supplemental nocturnal oxygen on 24-hour ambulatory blood pressure in 46 patients with moderate-severe OSA. We found that 2 weeks of CPAP therapy resulted in a significant reduction in daytime mean arterial and diastolic blood pressure and nighttime systolic, mean, and diastolic blood pressure (all Ps <0.05). Although nocturnal supplemental oxygen therapy improved oxyhemoglobin saturation, it did not affect blood pressure. We conclude that CPAP therapy reduces both daytime and nighttime blood pressure in patients with OSA, perhaps through mechanisms other than improvement of nocturnal oxyhemoglobin saturation.
Mesh Headings (Keywords): Adult, Blood Pressure, Blood Pressure Monitoring, Ambulatory, Circadian Rhythm, Continuous Positive Airway Pressure, Double-Blind Method, Drug Administration Schedule, Female, Humans, Male, Middle Aged, Oxygen, Sleep Apnea, Obstructive, Treatment Outcome
Check for Full Text / PubMed Unique Identifier (PMID): 16585412
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.